Truist Financial analyst Michael Lewis maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today. The company’s shares ...

Sabra Healthcare (SBRA) reported $182.35 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 11.6%. EPS of $0.36 for the same period compares to $0.07 a ...

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The health care real estate investment trust, based in Tustin, California, posted revenue of $182.3 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected ...

Besides Wall Street's top -and-bottom-line estimates for Sabra (SBRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the ...

REIT announced three promotions within its leadership team. Lukas Hartwich has been promoted to Executive Vice ...

SBRA currently has a PEG ratio of 1.99. Another notable valuation metric for CHCT is its P/B ratio of 1.15. The P/B is a method of comparing a stock's market value to its book value, which is ...